Authors


Stanley H. Appel, MD

Latest:

The Complexity of Frontotemporal Dementia and Potential of COYA 301: Stanley H. Appel, MD

The director of the Ann Kimball and John W. Johnson Center for Cellular Therapeutics at Houston Methodist Hospital discussed the clinical manifestations of frontotemporal dementia (FTD) and how Coya Therapeutics is moving toward precision medicine with their FTD candidate, COYA 301. [WATCH TIME: 4 minutes]


JayEtta Hecker

Latest:

Optimizing Care for SCN8A Epilepsy and Related Disorders: Gabi Conecker; JayEtta Hecker

Representatives from the SCN8A Alliance discussed ways to improve the quality of life for children with SCN8A-related epilepsy, highlighting the critical role of early genetic diagnosis and targeted interventions. [WATCH TIME: 4 minutes]


Ray Dorsey, MD

Latest:

Using New Models to Explore the Origins of Parkinson Disease: Ray Dorsey, MD

The professor of neurology at University of Rochester discussed a new model on how Parkinson disease may originate, highlighting potential environmental causes and progression. [WATCH TIME: 5 minutes]


Kuldip Dave, PhD

Latest:

Community Efforts to Standardize and Improve ALS Diagnosis: Kuldip Dave, PhD

The senior vice president of research at The ALS Association discussed the need for standardizing ALS diagnosis across institutions to reduce delays and ensure timely treatment. [WATCH TIME: 4 minutes]


William Bingaman, MD

Latest:

The Evolutionary Arch of Stereoelectroencephalography in the United States

SEEG has transformed the surgical investigation of refractory epilepsy, enabling clinicians to map complex seizure networks with precision, leading to more targeted treatment options for patients.


Kerri Neville, MD

Latest:

Recognizing Health Disparities in Infantile Spasms at Local and National Levels: Kerri Neville, MD

The pediatric neurologist and epileptologist at the University of Michigan's Mott Children's Hospital spoke at the 2022 AES conference about disparities that currently exist in epilepsy care. [WATCH TIME: 4 minutes]


Steve Hughes, MD

Latest:

Restoring Dystrophin Protein Production in DMD With Exon Skipping AOC Therapy: Steve Hughes, MD

The chief medical officer at Avidity Biosciences talked about how its exon skipping AOC therapies are designed to address the lack of functional dystrophin protein among patients with Duchenne muscular dystrophy to improve muscle function. [WATCH TIME: 4 minutes]


Jude Savarraj, PhD

Latest:

Jude Savarraj, PhD: Applying Machine Learning to Healthcare

The research scientist from the University of Texas Medical School discussed some of the challenges and opportunities that machine learning presents in patient care.


Linda Papa, MD, MSc, CCFP, FRCP(C), FACEP

Latest:

The Journey of Abbott’s Blood Test for Traumatic Brain Injury to the Clinical Setting: Linda Papa, MD, MSc, CCFP, FRCP(C), FACEP

The director of academic clinical research at Orlando Health reflected on the journey of a blood test for traumatic brain injury to clinical use, highlighting the collaborative efforts and patient participation that made it possible. [WATCH TIME: 3 minutes]


Jeffrey Huang, PhD

Latest:

Therapeutic Avenues for Multiple Sclerosis Through Immune Cell Communication: Jeffrey Huang, PhD

The associate professor of biology at Georgetown University talked about how immune cells can communicate with brain cells to enhance repair processes, which may offer potential treatment targets for multiple sclerosis. [WATCH TIME: 5 minutes]


Karin Johnson, MD, FAASM

Latest:

Impacts of Daylight Savings Time on Sleep, Overall Health: Karin Johnson, MD, FAASM

The professor of neurology at UMass Chan School of Medicine discussed the various impacts Daylight Savings Time has on sleep quality and overall health in children and adolescents. [WATCH TIME: 3 minutes]


Jennifer Majersik, MD, MS

Latest:

Clinicians’ Role in Addressing the Neurologist Shortage: Jennifer Majersik, MD, MS

The division chief of vascular neurology at the University of Utah discussed the individual role that clinicians and neurologists can play to increase interest in the field of neurology. [WATCH TIME: 2 minutes]


Henry Kaminski, MD

Latest:

Innovative MyClad Study Testing Cladribine Capsules in Generalized Myasthenia Gravis: Henry Kaminski, MD

The Meta A. Neumann Professor of Neurology at George Washington University provided an overview of a new phase 3 study testing the efficacy and safety of cladribine versus placebo in generalized myasthenia gravis. [WATCH TIME: 3 minutes]


Jennifer S. Hui, MD

Latest:

Living Up to the Gold Standard in Parkinson Disease: Jennifer S. Hui, MD

The assistant professor of neurology at the Keck School of Medicine at University of Southern California discussed the importance of having additional agents to treat Parkinson disease.


Jagan A. Pillai, MD, PhD

Latest:

Using Nonamnestic Cognitive Symptoms to Predict Trajectories of Neurodegenerative Disorders: Jagan A. Pillai, MD, PhD

The neurologist at Cleveland Clinic’s Lou Ruvo Center for Brain Health detailed new findings on whether initial cognitive symptoms have similar rates of functional decline across a handful of neurodegenerative disorders. [WATCH TIME: 3 minutes]


Tanisha Hill-Jarrett, PhD

Latest:

Understanding the Cognitive Impact of Neighborhood Disadvantage on Black Women: Tanisha Hill-Jarrett, PhD

The neuropsychologist and assistant professor of neurology at the University of California, San Francisco Memory and Aging Center provided comment on her presentation from AAN 2024 examining the association of area deprivation index with cognitive functioning in Black women. [WATCH TIME: 3 minutes]


Barbara C. Jobst, MD, PhD, FAAN, FAES

Latest:

Areas of Need in Epilepsy Research: Barbara Jobst, MD

The director of the Dartmouth Epilepsy Program provided an overview of some of the critical unmet needs within ongoing epilepsy research following the recent AES Annual Meeting.


Amy Kuceyeski, PhD

Latest:

Women's Neurology: Perspectives from the Ann S. Bowers Women's Brain Health Initiative

Nina Miolane, PhD, and Amy Kuceyeski, PhD, the codirectors of the Ann S. Bowers Women's Brain Health Initiative AI Core, provided their commentary on the challenges and progress made in women’s neurology.


Sucheta M. Joshi, MD

Latest:

Early Awareness Towards Epilepsy Transition

Sucheta M. Joshi, MD, MS, FAES, FAAP, and Nicholas Beimer, MD, discussed the reasons why EpiTRAQ may influence earlier discussions with patients prior to the epilepsy transition process.


Kim G. Johnson, MD

Latest:

Promising Innovative Gene Therapy for APOE4 Homozygous Alzheimer Disease: R. Nolan Townsend; Sandi See Tai, MD; Kim G. Johnson, MD

A trio of experts talked about Lexeo Therapeutics’ LX1001 gene therapy trial that demonstrated promising safety and biomarker effects in patients with early-stage Alzheimer disease. [WATCH TIME: 5 minutes]


Martha Morrell, MD

Latest:

Neurostimulation and Targeted Treatment Delivery in Epilepsy Care: Martha Morrell, MD

The clinical professor of neurology at Stanford University School of Medicine talked about the collaboration of Rapport leveraging NeuroPace’s data analysis capabilities to study the target delivery of a therapy for focal epilepsy. [WATCH TIME: 5 minutes]


Jason Poon, MD

Latest:

Diagnosis Through Teleneurology: Jason Poon, MD

The neurologist at University of Utah discussed the potential of using teleneurology to diagnose neurological conditions.


Michael Irizarry, MD, MPH

Latest:

Understanding Irsenontrine’s Role Among Neurodegenerative Disorders: Michael Irizarry, MD, PhD

The senior VP of clinical research at Eisai discussed findings from a phase 2 study assessing irsenontrine in patients with dementia with Lewy bodies and Parkinson disease dementia. [WATCH TIME: 4 minutes]


Mindy K. Bixby, DO

Latest:

Take-Home Messages for Managing OFF Episodes in PD

Mindy K. Bixby, DO and Laxman Bahroo, DO give key advice to community neurologists and emphasize the importance of effective communication between patients and providers.


Justin C. McArthur, MBBS, MPH

Latest:

AUPN Leadership Minute Episode 7: Keeping Morale of Faculty Up in Difficult Times

Episode 7 of the AUPN Leadership Minute features Donald S. Higgins Jr., MD, of the VHA; and Justin C. McArthur, MBBS, MPH, of Johns Hopkins University. [WATCH TIME: 4 minutes]


Nicholas Ashton, PhD

Latest:

Revolutionizing Alzheimer Disease Diagnosis with Blood Biomarkers: Nicholas Ashton, PhD

The associate professor of neurochemistry at the University of Gothenburg in Sweden talked about a pilot study that explored the potential of finger prick tests to remotely collect blood and provide reliable biomarker results for Alzheimer disease diagnosis. [WATCH TIME: 5 minutes]


Martina Bebin, MD, MPA

Latest:

Important Considerations for Infantile Spasms Awareness: Martina Bebin, MD, MPA

The professor of neurology at the University of Alabama at Birmingham Epilepsy Center provided comment on raising awareness for infantile spasms, especially during Infantile Spams Awareness Week, which is celebrated the first week of December. [WATCH TIME: 3 minutes]


Carol Rosen, MD

Latest:

Transitioning Sleep Schedules for School in Pediatric Patients: Carol Rosen, MD

The professor of pediatrics at Case Western University discussed the complexities and negative effects for children drastically change their sleep schedules as school begins. [WATCH TIME: 3 minutes]


Jessica Kiarashi, MD

Latest:

Equity in the Media and Academia

There should be a holistic approach to how the systems in place affect equity: how medicine is practiced and research is conducted, the structure of academic institutions, and how media influence our perceptions of neurologic conditions.


Chris Ryan

Latest:

FDA Approves Mirdametinib for NF1-Associated Plexiform Neurofibromas in Adults and Children

The kinase inhibitor was approved for patients with neurofibromatosis type 1 (NF1) who have symptomatic plexiform neurofibromas (PN) not amenable to complete resection.

© 2025 MJH Life Sciences

All rights reserved.